AU7187791A - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
AU7187791A
AU7187791A AU71877/91A AU7187791A AU7187791A AU 7187791 A AU7187791 A AU 7187791A AU 71877/91 A AU71877/91 A AU 71877/91A AU 7187791 A AU7187791 A AU 7187791A AU 7187791 A AU7187791 A AU 7187791A
Authority
AU
Australia
Prior art keywords
formula
benzopyrano
compound
pyrazol
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71877/91A
Other languages
English (en)
Inventor
Michael Henry Hockley
Roger Bernard Titman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of AU7187791A publication Critical patent/AU7187791A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU71877/91A 1990-02-06 1991-01-26 Therapeutic agents Abandoned AU7187791A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9002423 1990-02-06
GB909002423A GB9002423D0 (en) 1990-02-06 1990-02-06 Therapeutic agents

Publications (1)

Publication Number Publication Date
AU7187791A true AU7187791A (en) 1991-09-03

Family

ID=10670368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71877/91A Abandoned AU7187791A (en) 1990-02-06 1991-01-26 Therapeutic agents

Country Status (16)

Country Link
JP (1) JPH05504141A (enrdf_load_stackoverflow)
KR (1) KR927003600A (enrdf_load_stackoverflow)
AU (1) AU7187791A (enrdf_load_stackoverflow)
BR (1) BR9105990A (enrdf_load_stackoverflow)
CA (1) CA2074816A1 (enrdf_load_stackoverflow)
FI (1) FI923528A0 (enrdf_load_stackoverflow)
GB (1) GB9002423D0 (enrdf_load_stackoverflow)
HU (1) HUT63848A (enrdf_load_stackoverflow)
IE (1) IE910287A1 (enrdf_load_stackoverflow)
IL (1) IL97109A0 (enrdf_load_stackoverflow)
IN (1) IN172129B (enrdf_load_stackoverflow)
MX (1) MX24407A (enrdf_load_stackoverflow)
NO (1) NO923082L (enrdf_load_stackoverflow)
PT (1) PT96687A (enrdf_load_stackoverflow)
WO (1) WO1991012255A1 (enrdf_load_stackoverflow)
ZA (1) ZA91833B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116241D0 (en) * 1991-07-27 1991-09-11 Boots Co Plc Therapeutic agents
NZ540081A (en) 2002-11-22 2008-03-28 Active Biotech Ab Pyrazoloquinolines with immunomodulating activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA895646B (en) * 1988-08-09 1990-04-25 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
CA2074816A1 (en) 1991-08-07
IN172129B (enrdf_load_stackoverflow) 1993-04-10
BR9105990A (pt) 1992-11-10
ZA91833B (en) 1991-10-30
MX24407A (es) 1993-10-01
IL97109A0 (en) 1992-03-29
JPH05504141A (ja) 1993-07-01
HU9202540D0 (en) 1992-10-28
PT96687A (pt) 1991-10-31
GB9002423D0 (en) 1990-04-04
FI923528A7 (fi) 1992-08-05
NO923082D0 (no) 1992-08-05
WO1991012255A1 (en) 1991-08-22
IE910287A1 (en) 1991-08-14
NO923082L (no) 1992-08-05
HUT63848A (en) 1993-10-28
FI923528L (fi) 1992-08-05
FI923528A0 (fi) 1992-08-05
KR927003600A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
US5747486A (en) Thienopyridine or thienopyrimidine derivatives and their use
US5574168A (en) 1-(substituted benzyl)-3-(substituted aryl)-condensed pyrazole derivatives and processes of making the same
CA2211669A1 (en) 6-substituted pyrazolo [3,4-d¦ pyrimidin-4-ones and compositions and methods of use thereof
US5436247A (en) Quinoline or quinazoline derivatives, their production and use
CA1246563A (en) 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl- 1h-indoles useful as analgesics
JP2672312B2 (ja) ヘテロアリール３‐オキソ‐プロバンニトリル誘導体及びその製造方法
CS248035B2 (en) Production method of the(4(oxo-4h)1(-benzopyran-8-yl)carboxyle acides
EP0181136B1 (en) Oxindole antiinflammatory agents
US6214838B1 (en) Thienodipyridine derivatives, production and use thereof
NO802326L (no) Fremgangsmaate ved fremstilling av substituerte tetraazatricyklen
PT94729A (pt) Processo de preparacao de derivados de 1h-benzoxadiazina-4,1,2 e de composicoes farmaceuticas que os contem
CN102260253B (zh) 苯并[5,6]环庚基[1,2-b]吡啶衍生物、制备方法、药物组合物及其抗过敏性疾病的用途
US5075317A (en) Spirofurane derivatives
AU7187791A (en) Therapeutic agents
EP0354693A1 (en) Therapeutic agents
JPS63188665A (ja) ５−ヒドロキシインド−ル−３−カルボン酸エステル化合物
EP0539372A1 (en) Therapeutic agents
JPH04234359A (ja) １−ジフェニルメチルピペラジンの新規誘導体、それらの製法、及びそれらの医薬用途
JPH06199855A (ja) ピラゾロピリジン誘導体及びこれを含有する血小板凝集抑制剤
AU625915B2 (en) Synthesis of (1)-benzothiopyrano (4,3-c)-pyrazoles
US4454136A (en) Substituted benzopyranotriazoles and antiallergic use
IE922217A1 (en) Therapeutic agents
JPH0342276B2 (enrdf_load_stackoverflow)
EP0378358B1 (en) Anti-inflammmatory 1-heteroaryl-3-acyl-2-oxindoles
WO1986007357A3 (en) Cyclopentapyrazole and tetrahydroindazole compounds